参考文献/References:
[1] ALDUAIS Y, ZHANG Haijun, FAN Fan, et al. Nonsmall cell lung cancer (NSCLC): A review of risk factors, diagnosis, and treatment[J]. Medicine, 2023,102(8): e32899.
[2] REMON J, HENDRIKS L E L, MOUNTZIOS G, et al. MET alterations in NSCLC-current perspectives and future challenges[J]. Journal of Thoracic Oncology,2023, 18(4): 419-435.
[3] TSAMIS I, GOMATOU G, CHACHALI S P, et al. BRAF/MEK inhibition in NSCLC: mechanisms of resistance and how to overcome it[J]. Clinical & Translational Oncology, 2023, 25(1): 10-20.
[4] HU Chengyu. LncRNA DSCAM-AS1: A pivotal therapeutic target in cancer[J]. Mini Reviews in Medicinal Chemistry, 2023, 23(5): 530-536.
[5] 周立远, 叶玉祥, 林琳, 等.LncRNA CCAT1 调节miR-155 表达增强CD8+T 细胞对食管癌抗肿瘤活性的机制研究[J].现代检验医学杂志, 2023, 38(3):79-85. ZHOU Liyuan, YE Yuxiang, LIN Lin, et al. Mechanism of LncRNA CCAT1 regulating miR-155 expression and enhancing anti-tumor activity of CD8+T cells against esophageal cancer[J]. Journal of Modern Laboratory Medicine, 2023, 38(3): 79-85.
[6] DU Yong, YANG Haiyan, LI Yue, et al. Long noncoding RNA LINC01137 contributes to oral squamous cell carcinoma development and is negatively regulated by miR-22-3p[J]. Cellular Oncology (Dordrecht), 2021,44(3): 595-609.
[7] YAO Yuanshan, YANG Fuzhi, CHEN Anna, et al. Costimulatory molecule-related LncRNA model as a potential prognostic biomarker in non-small cell lung cancer[J]. Cancer Medicine, 2023, 12(5): 6419-6436.
[8] ZHANG Lili, MAO Bin, ZHAO Xiaodong, et al. Translation regulatory long non-coding RNA 1 (TRERNA1) sponges microRNA-23a to suppress granulosa cell apoptosis in premature ovarian failure[J].Bioengineered, 2022, 13(2): 2173-2180.
[9] 靳杨, 姜利琼, 房烨, 等.结直肠癌患者血清外泌体与组织中KRAS, BRAF, NRAS 和PIK3CA 基因突变检测及临床意义的比较[J]. 现代检验医学杂志,2023, 38(1): 22-26. JIN Yang, JIANG Liqiong, FANG Ye, et al. Comparison of KRAS, BRAF, NRAS and PIK3CA gene mutations in serum exosomes and tissues of patients with colorectal cancer and their clinical significance[J].Journal of Modern Laboratory Medicine, 2023, 38(1):22-26.
[10] ENTEZARI M, GHANBARIRAD M, TAHERIAZAM A, et al. Long non-coding RNAs and exosomal LncRNAs: Potential functions in lung cancer progression,drug resistance and tumor microenvironment remodeling[J]. Biomedecine & Pharmacotherapie,2022, 150: 112963.
[11] ZHAO Yarong, LIU Luotong, SUN Rongze, et al. Exosomes in cancer immunoediting and immunotherapy[J].Asian Journal of Pharmaceutical Sciences, 2022, 17(2):193-205.
[12] ADNANE S, MARINO A, LEUCCI E. LncRNAs in human cancers: signal from noise[J]. Trends in Cell Biology, 2022, 32(7): 565-573.
[13] HERMAN A B, TSITSIPATIS D, GOROSPE M. Integrated LncRNA function upon genomic and epigenomic regulation[J]. Molecular Cell, 2022, 82(12):2252-2266.
[14] RECK M, REMON J, HELLMANN M D. First-Line immunotherapy for non-small-cell lung cancer[J].Journal of Clinical Oncology, 2022, 40(6): 586-597.
[15] SUN Chengcao, ZHU Wei, LI Shujun, et al. FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway[J]. Genome Medicine, 2020, 12(1): 77.
[16] GAO Yanping, ZHANG Nannan, ZENG Zihang, et al. LncRNA PCAT1 activates SOX2 and suppresses radioimmune responses via regulating cGAS/STING signalling in non-small cell lung cancer[J]. Clinical and Translational Medicine, 2022, 12(4): e792.
[17] HUANG Yusheng, XIA Lei, TAN Xiangwu, et al. Molecular mechanism of LncRNA SNHG12 in immune escape of non-small cell lung cancer through the HuR/PD-L1/USP8 axis[J]. Cellular & Molecular Biology Letters, 2022, 27(1): 43.
[18] ZHUANG Jinman, CHEN Zhongwu, CHEN Zishan,et al. Construction of an immune-related LncRNA signature pair for predicting oncologic outcomes and the sensitivity of immunosuppressor in treatment of lung adenocarcinoma[J]. Respiratory Research, 2022,23(1): 123.
[19] WANG Xinyi, JING Hui, LI Hecheng. A novel cuproptosis-related LncRNA signature to predict prognosis and immune landscape of lung adenocarcinoma[J]. Translational Lung Cancer Research, 2023, 12(2): 230-246.
[20] KO?AT D, KA?UZI?SKA-KO?AT ?, KO?LA K,et al. LINC01137/miR-186-5p/WWOX: a novel axis identified from WWOX-related RNA interactome in bladder cancer[J]. Frontiers in Genetics, 2023, 14:1214968.
[21] ZHU Le, SUN Haoting, WANG Shun, et al. Isolation and characterization of exosomes for cancer research[J].Journal of Hematology & Oncology, 2020, 13(1): 152.
[22] HE Jiao, REN Weihong, WANG Wei, et al. Exosomal targeting and its potential clinical application[J]. Drug Delivery and Translational Research, 2022, 12(10):2385-2402.
[23] NI Jianjiao, ZHANG Xiaofei, LI Juan, et al. Tumourderived exosomal LncRNA-SOX2OT promotes bone metastasis of non-small cell lung cancer by targeting the miRNA-194-5p/RAC1 signalling axis in osteoclasts[J].Cell Death & Disease, 2021, 12(7): 662.
[24] L? Xin, LIAN Yingjie, LIU Zhanye, et al. Exosomal long non-coding RNA LINC00662 promotes non-small cell lung cancer progression by miR-320d/E2F1 axis[J].Aging, 2021, 13(4): 6010-6024.
[25] GAO Jian, AO Yongqiang, ZHANG Lingxian, et al. Exosomal circZNF451 restrains anti-PD1 treatment in lung adenocarcinoma via polarizing macrophages by complexing with TRIM56 and FXR1[J]. Journal of Experimental & Clinical Cancer Research, 2022, 41(1):295.
[26] GUNASSEKARAN G R, POONGKAVITHAI VADEVOO S M, BAEK M C, et al. M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages[J]. Biomaterials, 2021, 278:121137.
[27] DOLINA J S, VAN BRAECKEL-BUDIMIR N,THOMAS G D, et al. CD8+ T Cell exhaustion in cancer [J]. Frontiers in Immunology , 2021, 12:715234.
[28] VAN D L A M. THOMMEN D S, SCHUMACHER T N.CD8+T cell states in human cancer:insights from single-cell analysis[J]. Nature Reviews Cancer, 2020,20(4): 218-232.
[29] KIM C G, KIM G, KIM K H, et al. Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer[J]. Journal for Immunotherapy of Cancer, 2021, 9(12): e002780.
[30] VADLA G P, DAGHAT B, PATTERSON N, et al. Combining plasma extracellular vesicle Let-7b-5p,miR-184 and circulating miR-22-3p levels for NSCLC diagnosis and drug resistance prediction[J]. Scientific Reports, 2022, 12(1): 6693.
[31] HE Wenlong, ZHANG Yeying, XIA Shulan. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis[J]. Thoracic Cancer, 2020, 11(3): 549-560.
[32] SHENG Jin, WANG Huadi, LIU Xiao, et al. Deep sequencing of T-Cell receptors for monitoring peripheral CD8+ T cells in Chinese advanced nonsmall-cell lung cancer patients treated with the anti-PD-L1 antibody[J]. Frontiers in Molecular Biosciences,2021, 8: 679130.
相似文献/References:
[1]张 蕾,任亚女,曾婷婷,等.晚期非小细胞肺癌患者血液实验指标和病理分期等因素对生存时间的影响分析[J].现代检验医学杂志,2016,31(02):83.[doi:10.3969/j.issn.1671-7414.2016.02.025]
ZHANG Lei,REN Ya-n,ZENG Ting-ting,et al.Analysis of Prognosis Related Factors in Patients
with Advanced Non-Small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2016,31(02):83.[doi:10.3969/j.issn.1671-7414.2016.02.025]
[2]薛鸿涛,任 敏,李长彬.非小细胞肺癌患者放疗前后血清TSGF和CRP的变化及其临床意义[J].现代检验医学杂志,2016,31(02):136.[doi:10.3969/j.issn.1671-7414.2016.02.041]
XUE Hong-tao,REN Min,LI Chang-bin.Impact and Clinical Significance of Radiotherapy on Serum
TSGF and CRP in Patients with Non Small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2016,31(02):136.[doi:10.3969/j.issn.1671-7414.2016.02.041]
[3]王京伟,李 艳,童永清,等.湖北地区非小细胞肺癌EGFR 基因突变及其意义的研究[J].现代检验医学杂志,2016,31(03):7.[doi:10.3969/j.issn.1671-7414.2016.03.003]
WANG Jing-wei,LI Yan,TONG Yong-qing,et al.Detection of Epidermal Growth Factor Receptor(EGFR)
Mutations and the Significance in Patients with Non-small Cell Lung
Cancer(NSCLC)of Hubei Province[J].Journal of Modern Laboratory Medicine,2016,31(02):7.[doi:10.3969/j.issn.1671-7414.2016.03.003]
[4]易甲其,范艳平,周宁加,等.血清PTX-3,CYFRA21-1和TPS在非小细胞肺癌中的变化及临床意义[J].现代检验医学杂志,2015,30(05):58.[doi:10.3969/j.issn.1671-7414.2015.05.018]
YI Jia-qi,FAN Yan-ping,ZHOU Ning-jia,et al.Changes and Clinical Significance of Serum PTX-3,
CYFRA21-1,TPS in Non-Small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2015,30(02):58.[doi:10.3969/j.issn.1671-7414.2015.05.018]
[5]钱忠萍,凌 晨,祁松楠,等.围非小细胞肺癌手术期T细胞含量变化的研究[J].现代检验医学杂志,2016,31(05):55.[doi:10.3969/j.issn.1671-7414.2016.05.014]
QIAN Zhong-ping,LING Chen,QI Song-nan,et al.Content Variation of T Cells in Perioperative Patients
with Non-Small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2016,31(02):55.[doi:10.3969/j.issn.1671-7414.2016.05.014]
[6]黎谢梦丹,罗 凯,吴顺芳,等.华南地区非小细胞肺癌患者肿瘤组织EGFR,ALK和ROS1基因突变分析[J].现代检验医学杂志,2017,32(05):16.[doi:10.3969/j.issn.1671-7414.2017.05.005]
LIXIE Meng-dan,LUO Kai,WU Shun-fang,et al.Mutation Analysis of EGFR,ALK and ROS1 in Tumor Tissues
of Patients with Non-Small Cell Lung Cancer in South of China[J].Journal of Modern Laboratory Medicine,2017,32(02):16.[doi:10.3969/j.issn.1671-7414.2017.05.005]
[7]李小龙,白巧艳,陆婉玲.老年非小细胞肺癌患者低分割放疗对凝血功能的影响[J].现代检验医学杂志,2018,33(05):142.[doi:10.3969/j.issn.1671-7414.2018.05.039]
LI Xiao-long,BAI Qiao-yan,LU Wan-ling.Influence of Hypofractionated High-Dose Radiotherapy on Coagulation Function in Elderly Patients with Non-Small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2018,33(02):142.[doi:10.3969/j.issn.1671-7414.2018.05.039]
[8]郭 华a,齐宗利a,张海祥b,等.非小细胞肺癌组织EGFR/ALK/ROS1基因联合检测的临床意义[J].现代检验医学杂志,2018,33(06):17.[doi:10.3969/j.issn.1671-7414.2018.06.005]
GUO Huaa,QI Zong-lia,ZHANG Hai-xiangb,et al.Clinical Significance of Combined Detection of EGFR/ALK/ROS1 Genes in Non-Small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2018,33(02):17.[doi:10.3969/j.issn.1671-7414.2018.06.005]
[9]黄 刚,陈 霏,肇玉博,等.非小细胞肺癌患者血浆miRNA-145和miRNA-221表达与临床特征及术后复发的相关性研究[J].现代检验医学杂志,2019,34(04):40.[doi:10.3969/j.issn.1671-7414.2019.04.010]
HUANG Gang,CHEN Fei,ZHAO Yu-bo,et al.Study on the Correlation between the Expression of MicroRNA145
and MicroRNA221 in Plasma and Clinical Characteristics and
Postoperative Recurrence in Patients with Non-Small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2019,34(02):40.[doi:10.3969/j.issn.1671-7414.2019.04.010]
[10]蒋玲丽,黄中强,王雪亮,等.表皮生长因子受体(EGFR)基因突变检测质控品制备及应用[J].现代检验医学杂志,2020,35(02):145.[doi:10.3969/j.issn.1671-7414.2020.02.040]
JIANG Ling-li,HUANG Zhong-qiang,WANG Xue-liang,et al.Development and Application of Quality Control Materials for EpidermalGrowth Factor Receptor (EGFR)Mutation Determination[J].Journal of Modern Laboratory Medicine,2020,35(02):145.[doi:10.3969/j.issn.1671-7414.2020.02.040]